Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Trump says US ready to aid Russia with plague outbreak in Siberia

Russian authorities quarantine hospital, monitor 200 contacts after suspected pneumonic plague death in Siberia.

Secretary of State Marco Rubio emphasized on Monday that the United States is closely monitoring the situation surrounding a laboratory worker who passed away at a plague research institute in Siberia. Speaking to reporters before embarking on a European trip, Rubio stated that while the incident is not a reason for alarm, it warrants attention and continued monitoring.

The worker at the Irkutsk Anti-Plague Research Institute, located in Siberia and the Far East, fell ill and subsequently died under unclear circumstances. This triggered the quarantine of numerous individuals and prompted the head of Russia's health watchdog to travel to the region. Conflicting reports emerged regarding the manner and location of the worker's infection, but authorities confirmed the cause of death as pneumonia.

Rubio, basing his assessment on information released by Russian authorities, inferred that there was a laboratory worker who contracted the disease, raising concerns about potential internal spread. Despite the limited travel between the U.S. and Russia, Rubio stressed that any situation of this nature requires vigilance.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at aljazeera.com →

More in Health & Medicine

Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease Identified

A study in human monocyte-derived microglia and human brain tissue slices suggests that inflammatory brain conditions, including traumatic brain injury and neurodegenerative diseases such as…

  • Anti-inflammatory drug targets Alzheimer's, TBI, and neurodegenerative diseases.
  • P2X7 receptor blocking reduces pro-inflammatory cytokine release in human brain cells.
  • P2X7R antagonists curb microglial activity, offering new therapeutic approach.

More from Monday 5 October →